SCOPUS 정보 검색 플랫폼

Volumn 55, Issue 2, 2006, Pages 44-46

High levels of adamantane resistance among influenza a (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; ANTIVIRUS AGENT;

ANTIBIOTIC RESISTANCE; DRUG EFFECT; HUMAN; INFLUENZA; INFLUENZA VIRUS A H3N2; PRACTICE GUIDELINE; REVIEW; SEASON; UNITED STATES;

ADAMANTANE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; PRACTICE GUIDELINES; SEASONS; UNITED STATES;

EID: 32544442997 PISSN: 01492195 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (148)

References (9)

1
- 4544332903
- Influenza-associated hospitalizations in the United States
- Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-40.
- (2004) JAMA , vol.292 , pp. 1333-1340
- Thompson, W.W.¹ Shay, D.K.² Weintraub, E.³

2
- 0037425564
- Mortality associated with influenza and respiratory syncytial virus in the United States
- Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
- (2003) JAMA , vol.289 , pp. 179-186
- Thompson, W.W.¹ Shay, D.K.² Weintraub, E.³

3
- 0023877609
- Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
- Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol 1988;62:1508-12.
- (1988) J Virol , vol.62 , pp. 1508-1512
- Belshe, R.B.¹ Smith, M.H.² Hall, C.B.³ Betts, R.⁴ Hay, A.J.⁵

4
- 25844438380
- Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern
- Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005;366:1175-81.
- (2005) Lancet , vol.366 , pp. 1175-1181
- Bright, R.A.¹ Medina, M.J.² Xu, X.³

5
- 0025983151
- Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets
- Sweet C, Hayden FG, Jakeman KJ, Grambas S, Hay AJ. Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. J Infect Dis 1991;164:969-72.
- (1991) J Infect Dis , vol.164 , pp. 969-972
- Sweet, C.¹ Hayden, F.G.² Jakeman, K.J.³ Grambas, S.⁴ Hay, A.J.⁵

6
- 25444501243
- Neuraminidase inhibitors for influenza
- Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-73.
- (2005) N Engl J Med , vol.353 , pp. 1363-1373
- Moscona, A.¹

7
- 32544450753
- Rockville, MD: Food and Drug Administration
- Food and Drug Administration. FDA news: FDA approves Tamiflu for prevention of influenza in children under age 12. Rockville, MD: Food and Drug Administration; 2005. Available at http://www.fda.gov/bbs/topics/news/2005/ new01285.html.
- (2005) FDA News: FDA Approves Tamiflu for Prevention of Influenza in Children under Age 12

8
- 23044467137
- Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
- CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54(No. RR-8).
- (2005) MMWR , vol.54 , Issue.RR-8

9
- 32544433606
- Update: Influenza activity - United States, December 25-31, 2005
- CDC. Update: influenza activity - United States, December 25-31, 2005. MMWR 2006;55:11-3.
- (2006) MMWR , vol.55 , pp. 11-13

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.